12.01.2022 / Deals & Cases
Deal: Creoptix joins Malvern Panalytical family
Malvern Panalytical, a Worcestershire (England) based company providing advanced analysis and services solutions for the pharma drug product development, as well as services and solutions for other industries, has announced its acquisition of Creoptix AG, a specialist bioanalysis sensor company. Creoptix AG provides cutting edge tools for molecular interaction analysis through its WAVEsystem of next-generation bioanalytical instruments. The WAVEsystem offers a breakthrough level of kinetics analysis. The acquisition forms a critical part of Malvern Panalytical’s strategy to expand its capabilities in support of drug discovery.
Founded in 2009, Creoptix AG is headquartered in Wädenswil, near Zurich with a US subsidiary in the Boston area.
We advised the shareholders of Creoptix AG on this transaction regarding all legal aspects. Our team was led by Beat Speck (Partner, M&A / Corporate) and included Barbara Brauchli (Partner / Tax), Anna Tomaschek (Associate, M&A / Corporate), and Matea Brezovic (Junior Lawyer, M&A / Corporate).